Merck Millipore acquires rights for Biotest microbiology products
Merck Millipore now has exclusive rights to sell Biotest microbiology products in Australia and New Zealand.
In 2011, Merck Millipore acquired German company Biotest, an innovative industrial microbiology company with capabilities in ready-to-use media and hygiene monitoring. Its products are targeted at the pharmaceutical and food and beverage segments.
Biotest’s microbiology products, previously marketed by either of their two trading companies, Heipha and Hycon, are now exclusively available through Merck Millipore. Technical support for the products is also offered.
2026 Nobel Prize winners announced
It's that time of year again — the first of the 2026 Nobel Prizes have been announced.
NSW Govt to launch science and innovation fund
The fund will be used to coordinate strategic investments, deliver on government priorities and...
DKSH brings Bioyond Robotics' lab automation products Down Under
DKSH will provide distribution of the Bioyond Robotics portfolio of AI-driven autonomous...
